618O A phase I study of TRS005: An anti-CD20-MMAE antibody-drug conjugate, in relapsed or refractory b cell non-Hodgkin lymphoma

Antibody-drug conjugate Conjugate Refractory (planetary science)
DOI: 10.1016/j.annonc.2022.07.744 Publication Date: 2022-09-13T18:46:15Z